Concepedia
Publication | Open Access
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen
37
Citations
30
References
2023
Year
ClinicalTrials.gov Identifier: NCT01356290.
Page 1